Over 20 years of experience in R&D

01 Drug Discovery

Chemistry Research

Biology Research

Early Pharmacokinetics

02 Pharmaceutical Research

Intermediates

Active Pharmaceutical Ingredients

Pharmaceutical preparation

Analytical Method Development and Quality Control

CMC Filings

Analytical Testing Center

03 Preclinical Research

Pharmacology & Pharmacodynamics

Drug Safety Evaluation

DMPK

Bioanalysis

IND Filings

01 One-stop Integrated Services

Liposome Drug Development

Drug Discovery

Pharmaceutical Research

Preclinical Research

Botanical Drug Preclinical R&D

02 Innovative Drug Services

ADC

PROTAC

mRNA Vaccine

Cellular Immunotherapies

Nucleic Acid Drug

Peptide Drug Conjugate (PDC)

Antibody

03 Key Technical Services for Drug R&D

Cytokine and Biomarker Detection

Metabolite Identification (MetID)

Drug Forming Research

Flow Cytometry Technology

SEND Format Conversion

Flow Sorting

NanoString nCounter Detection

Routes of Drug Administration

04 Drug Efficacy Evaluation for Common Diseases

IO Pharmacodynamic Model

Inflammatory and Immune Diseases

Rodent Cerebrovascular Disease

05 Advanced Preparation R&D

Inhalation drug

Ophthalmic drug

Skin Topical Preparation

06 Targeted Drugs R&D Services

STAT3-targeted Drugs R&D Service

GLP-1 New Drug R&D Service

KRAS-targeted Drugs R&D Service

2024-07-22Medicilon Events

The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together

On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.

Learn more

2024-07-22Medicilon Events

5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"

Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.

Medicilon 688202

RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER

Intellectual Property Protection

U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Shanghai Public Network Security File No. 31011502018888 | Website Map

Preclinical Research

FAQs

HomeservicesPreclinical ResearchPharmacology & PharmacodynamicsCardiovascular Model

Cardiovascular Model

Medicilon has established many cardiovascular models including the Dyslipidemia, Thrombosis & anemia, MCAO, and Anemia models for pharmacodynamics research.

Disease	Type	Species
Dyslipidemia	Hyperlipidemia model (HFD/Cholesterol /Fructose diet induction)	Rat/ Hamster
Dyslipidemia	Hereditary atherosclerosis+HFD	APOE Mouse
Thrombosis, Anticoagulation, Hemophilia	Arteriovenous bypass thrombosis model	Mouse/ Rat
	Caudal vein thrombosis (Carrageenan induction)	Mouse
	Rat model of deep vein thrombosis	Rat
	Carotid artery thrombosis model	Mouse/Rat
	Bleeding time (BT) test	Mouse
	Coagulation time (CT) test	Mouse
	Four tests for coagulation (PT, APTT, TT, FIB)	Mouse/Rat
	F8-KO hemophilia model	Mouse
Middle Cerebral Artery Occlusion(MCAO)	Cerebral ischemia reperfusion: dose-dependent and time-effect relationship research	Mouse/Rat
	Time window for treatment of cerebral ischemia reperfusion injury	Mouse/Rat
	The neuroprotective effect of cerebral ischemia reperfusion	Mouse/Rat
	Permanent cerebral infarction model	Rat
Myocardial ischemia-reperfusion	Myocardial ischemia-reperfusion model	Rat
Anemia	Hypoferric anemia	Rat
	Renal anemia induced by 5/6 Nephrectomy	Rat
	Renal anemia induced by adenine	Rat

Cardiovascular and cerebrovascular diseases generally refer to ischemic or hemorrhagic diseases of the heart, brain and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, and hypertension. Medicilon has established rat and mouse MCAO model evaluation system with stable lesions, high success rate, high survival rate and reliable and effective evaluation of dose-effect/time-effect relationship. We can provide efficacy evaluation of transient cerebral ischemia and permanent cerebral ischemia and complete the investigation of various pharmacodynamic core indicators according to STAIR technical guidelines. The model rodents could be customized with special diseases and complete activity evaluations according to customer requirements.

Disease Name	ICD 10	Model
Intracerebral hemorrhage	I60-I62	Intracranial autologous blood injection, subarachnoid hemorrhage
Cerebral infarction	I63	Ischemic stroke model
Stroke	I64
Cerebral Embolism	I65
Cerebral Embolism	I66
Other	I67-I69	Other

Relevant articles

Digestive System Disease Models Endocrine & Metabolic Disease Models Inflammatory & Immune Diseases Models Neural System Disease Models Other Disease Models PDXO Models